| Model Number |
FGS-0636 |
| Medical Device Problem Code |
Separation Failure (2547)
|
| Health Effect - Clinical Codes |
Oversedation (1990); No Clinical Signs, Symptoms or Conditions (4582)
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
D10 concomitant products: unk-bravo, unknown bravo (lot#: unknown).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that the capsule failed to attach.The delivery device was withdrawn, and the capsule fell to the floor as the delivery device left the mouth.Another capsule was attempted to be used and it was unsuccessful.Additional propofol anesthesia time was needed due to the issue.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: b5, g3.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that the capsule failed to attach.The delivery device was withdrawn, and the capsule fell to the floor as the delivery device left the mouth.Another capsule was attempted to be used and it was unsuccessful as the same issue occurred.The second capsule came out on the delivery device loosely attached.Additional propofol anesthesia time was needed due to the issue.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: b5, g3, h6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that the capsule failed to attach.The delivery device was withdrawn, and the capsule fell to the floor as the delivery device left the mouth.Another capsule was attempted to be used and it was unsuccessful as the same issue occurred.The second capsule came out on the delivery device loosely attached.Additional propofol anesthesia time was needed due to the issue.There was no patient or user harm.
|
| |
|
Additional Manufacturer Narrative
|
|
D10 concomitant product: fgs-0636, fgs-0636 cf delivery dev caps bravo x1 (lot#67031f) additional information: d9, g3, h3, h6 h3 evaluation summary: medtronic conducted an investigation based upon all information received.The capsule and delivery system were returned for evaluation.Visual inspection of the delivery device and capsule found no notable conditions.It was reported that device failed to detach from delivery system during use.The reported issue was confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|